Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes.

Ma, Zhulin; Christiansen, Jens Sandahl; Laursen, Torben; Wu, Chunsen; Lauritzen, Torsten; Parkner, Tina; Frystyk, Jan

Ma, Zhulin; Christiansen, Jens Sandahl; Laursen, Torben; Wu, Chunsen; Lauritzen, Torsten; Parkner, Tina; Frystyk, Jan.

Afiliação

Ma Z; Medical Research Laboratory, Department of Clinical Medicine, Faculty of Health, Aarhus University, DK-8000 Aarhus C, Denmark. zhulin.ma@ki.au.dk.

BMC Endocr Disord ; 14: 35, 2014 Apr 11.

Article em En | MEDLINE | ID: mdl-24725803

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986432
https://dx.doi.org/10.1186/1472-6823-14-35

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986432
https://dx.doi.org/10.1186/1472-6823-14-35

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article